Myra Solano Garcia, who has Alzheimer’s, says the drug Kisunla may be one reason she can still drive, cook, and sing.

Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband isn't sure if it made a difference.

Eisai (ESALF) delivered another quarter with Leqembi growth, which is picking up strongly on a sequential basis. Read why I'm ...